Commentary · 21 Feb 2026
Conference abstractPublished 21 Oct 2013
Association between COX-2 gene polymorphisms and head and neck cancers risk in a Chinese Han population
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recent findings have revealed that a wide range of cancer therapeutic agents activate autophagy, a process that often functions as a pro-survival ("self-cleaning") mechanism responsible for limited efficacy of and resistance to such agents. However, because autophagy can act as a ?double-edged sword? in cancer (e.g., in addition to its cytoprotective actions, excessive autophagy can also trigger cell death), whether autophagy should be inhibited or activated in cancer treatment has become the subject of considerable debate. Currently, it is widely accepted that the mechanisms by which autophagy is perturbed may determine the outcome of autophagy-targeting therapies. This lecture will discuss a variety of issues and challenges related to current autophagy-targeting therapeutic strategies. It will then introduce a novel approach targeting the cargo-loading process of selective autophagy. The net effect of this strategy is to disable cargo loading into autophagosomes, a critical step required for efficient removal of misfolded or unfolded proteins by selective autophagy through fusion with lysosomes. It will also present a novel cross-talk between autophagy and apoptosis, via which a cytoprotective autophagic resopnse can be switched to pro-death response to benefit various cancer therapies. These new findings will provide a theoretical basis for an entirely new autophagy-directed strategy which could be immediately translatable to the treatment of human cancers.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Yu-Ming Niu”
- BylineArticles whose byline prints “Hua Yuan”
- BylineArticles whose byline prints “Ming Shen”
- BylineArticles whose byline prints “Hui-Zhang Li”
- BylineArticles whose byline prints “Yuan-Yuan Hu”
- BylineArticles whose byline prints “Ning Chen”
